Current advances in skin-on-a-chip models for drug testing.
Current advances in skin-on-a-chip models for drug testing.
复制标题
DOI:
10.21037/mps.2018.08.01
复制
发表时间:
2018-08
期刊:
影响因子:
--
通讯作者:
Qiang Zhang;L. Sito;Mao Mao-Mao;Jiankang He;Yu Zhang;Xin Zhao
中科院分区:
文献类型:
--
作者:
Qiang Zhang;L. Sito;Mao Mao-Mao;Jiankang He;Yu Zhang;Xin Zhao
Skin-on-a-chip models are highly desirable in drug testing compared to conventional 2D cell culture and animal models as they can replicate organ-specific 3D structural organization and physiological functions at a relatively low cost. To engineer a physiologically relevant skin model, human skin structures have been integrated onto microfluidic platforms to construct skin-on-a-chip systems that can mimic the complex in vivo situation. In this mini-review, we first briefly introduce some critical technologies employed to develop in vitro skin-on-a-chip models. We then review the applications of the state-of-the-art skin-on-a-chip models in drug testing, with a focus on using models of full-thickness skin equivalents (FTSEs), skin models with additional components such as vasculature, immune cells and hair follicles as well as multi-organ-on-a-chip models. Finally, we discuss some current challenges and future directions of development of complex, and in vivo-like skin-on-a-chip models.